Results 191 to 200 of about 15,767 (251)

Identification of mono-ADP-ribose readers using well-defined photoaffinity-based probes. [PDF]

RSC Chem Biol
van der Heijden FLAM, Weijers SA, Kondyli S, Bleijerveld O, Vermeulen M, Filippov DV.   +5 more
europepmc   +1 more source

Design, Synthesis, and Evaluation in Vitro of Quinoline-8-carboxamides, a New Class of Poly(adenosine-diphosphate-ribose)polymerase-1 (PARP-1) Inhibitor

, 2008
Anna-Marie Lord, Mary F. Mahon, Matthew D. Lloyd, Michael D. Threadgill   +3 more
openalex   +1 more source

Specificity and recognition of the ADP-ribosyl-ubiquitin modification in the DNA damage response. [PDF]

PLoS Biol
Chatrin C, Zhu K, Simmons MDR, Maginn L, Schützenhofer K, Lu Y, Đukić N, Wijngaarden S, Kloet MS, Kliza KW, Heden van Noort GJV, Filippov DV, Ahel D, Smith R, Ahel I.   +14 more
europepmc   +1 more source

Versatile and sensitive detection of mono- and poly(ADP-ribosyl)ation reveals XRCC1-dependent remodelling of PARP1 signalling. [PDF]

Nat Commun
Dauben H, Mihaljević M, Kolvenbach A, Palumbieri MD, Kapsali C, Huppertz I, Matić I.   +6 more
europepmc   +1 more source

ADP-Ribosylation of Cytidine: A Novel Nucleic Acid Modification Reversed by NADAR Hydrolases. [PDF]

Toxins (Basel)
Mikolčević P, Hloušek-Kasun A, Schuller M, Lu Y, Pirović E, Ahel I, Mikoč A.   +6 more
europepmc   +1 more source

Production of poly(adenosine diphosphate-ribose) polymerase-1: development of an efficient production and purification protocol

, 2003
Matthew I. Knight
openalex   +1 more source

Treatment of HRD-positive elderly ovarian cancer patient: a case report. [PDF]

Anticancer Drugs
Jiang Y, Yi Q, Wang Y, Li C, Liu H.
europepmc   +1 more source

Efficacy and safety of PARP inhibitors in metastatic breast cancer patients with homologous recombination repair pathway gene mutations: a retrospective multicenter real-world study. [PDF]

Ther Adv Med Oncol
Peng X, Song R, Fan Y, Wang J, Li Q, Mo H, Wang J, Luo Y, Chen S, Sun X, Zhang J, Zhang P, Xu B, Lan B, Ma F.   +14 more
europepmc   +1 more source

Receipt of PARP Inhibitors in Patients With Metastatic Prostate Cancer Harboring BRCA1/2 Alterations.

JAMA Netw Open
Ostrowski M, Jo Y, Hage Chehade C, Ozay ZI, Gebrael G, Sayegh N, Lin E, Srivastava A, Gordhamer A, Ji R, Li H, Mathew Thomas V, Gupta S, Riaz IB, Maughan BL, Roy S, Agarwal N, Swami U.   +17 more
europepmc   +1 more source

The 5' Cap Epitranscriptome and Beyond: Natural and Engineered 5' Cap Modifications for Optimizing mRNA Therapeutics and Functional Studies. [PDF]

ChemMedChem
Dahm GC, Pieper M, Schepers H, Rentmeister A.   +3 more
europepmc   +1 more source